Tisdag 16 December | 12:42:43 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-02-16 08:30 Bokslutskommuniké 2026
2026-11-03 08:30 Kvartalsrapport 2026-Q3
2026-09-01 08:30 Kvartalsrapport 2026-Q2
2026-04-28 08:30 Kvartalsrapport 2026-Q1
2026-02-16 08:30 Bokslutskommuniké 2025
2025-11-03 - Kvartalsrapport 2025-Q3
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2025-05-28 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-14 - Bokslutskommuniké 2024
2024-11-01 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-31 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2024-05-30 - Årsstämma
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-09 - Bokslutskommuniké 2023
2023-12-21 - Extra Bolagsstämma 2024
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-04-06 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2023-04-05 - Årsstämma
2023-02-03 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-10-05 - Extra Bolagsstämma 2022
2022-08-26 - Kvartalsrapport 2022-Q2
2022-06-15 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2022-06-14 - Årsstämma
2022-04-29 - Kvartalsrapport 2022-Q1
2022-02-18 - Bokslutskommuniké 2021
2021-11-29 - Kvartalsrapport 2021-Q3
2021-09-23 - Extra Bolagsstämma 2021
2021-08-30 - Kvartalsrapport 2021-Q2
2021-06-28 - Årsstämma
2021-06-15 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-19 - Bokslutskommuniké 2020
2020-11-09 - Kvartalsrapport 2020-Q3
2020-08-17 - Kvartalsrapport 2020-Q2
2020-06-26 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2020-06-25 - Årsstämma
2020-05-11 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-05-10 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2019-05-06 - Kvartalsrapport 2019-Q1
2019-04-10 - Årsstämma
2019-02-28 - Bokslutskommuniké 2018
2018-12-18 - Extra Bolagsstämma 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-12 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2018-04-11 - Årsstämma
2018-03-22 - Bokslutskommuniké 2017
2017-08-29 - Kvartalsrapport 2017-Q2
2017-05-09 - Kvartalsrapport 2017-Q1
2017-04-26 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2017-04-25 - Årsstämma
2017-02-24 - Bokslutskommuniké 2016
2016-11-16 - Kvartalsrapport 2016-Q3
2016-10-19 - Extra Bolagsstämma 2016
2016-08-31 - Kvartalsrapport 2016-Q2
2016-04-20 - Kvartalsrapport 2016-Q1
2016-02-25 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2016-02-24 - Årsstämma
2016-02-04 - Bokslutskommuniké 2015
2015-11-13 - Kvartalsrapport 2015-Q3
2015-09-04 - Kvartalsrapport 2015-Q2
2015-07-22 - Extra Bolagsstämma 2015
2015-05-07 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2015-05-06 - Årsstämma
2015-04-17 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-12-17 - Extra Bolagsstämma 2014
2014-11-28 - Kvartalsrapport 2014-Q3
2014-11-14 - Kvartalsrapport 2014-Q3
2014-08-29 - Kvartalsrapport 2014-Q2
2014-06-12 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2014-06-11 - Årsstämma
2014-05-16 - Kvartalsrapport 2014-Q1
2014-02-21 - Bokslutskommuniké 2013
2013-11-15 - Kvartalsrapport 2013-Q3
2013-08-28 - Kvartalsrapport 2013-Q2
2013-06-17 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2013-06-14 - Årsstämma
2013-05-17 - Kvartalsrapport 2013-Q1
2013-02-22 - Bokslutskommuniké 2012
2012-11-30 - Kvartalsrapport 2012-Q3
2012-07-31 - Kvartalsrapport 2012-Q2
2012-06-20 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2012-06-19 - Årsstämma
2012-04-20 - Kvartalsrapport 2012-Q1
2012-02-21 - Bokslutskommuniké 2011
2011-11-04 - Kvartalsrapport 2011-Q3
2011-08-12 - Kvartalsrapport 2011-Q2
2011-05-06 - Kvartalsrapport 2011-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
iZafe Group är ett Life Science-bolag inriktat på utveckling och marknadsföring av digitala medicinska lösningar för läkemedelshantering i hemmet. Bolaget erbjuder bland annat en läkemedelsrobot, SaaS-lösningar och en uppkopplad dosettask. Produkterna ämnar minska risken för felmedicinering. Kunderna utgörs av privatpersoner, läkemedelsbolag samt offentliga och privata vårdgivare globalt. iZafe Group har sitt huvudkontor i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-12-08 10:00:00

November marked yet another month of strong progress. New municipal rollouts, additional signed agreements, and continued growing interest all confirm that we are firmly establishing ourselves as one of the most attractive options for safe and digital medication management both in Sweden and across our expanding European markets, where interest is rising notably in the Netherlands. We continue to grow in usage, in partnerships, and in geographic presence, building steadily on the foundation laid throughout the year.

We are now working intensively to deliver as many Dosell units as possible before year-end. Each delivery contributes directly to our recurring revenue and is therefore central to meeting our communicated forecasts.

Sweden – More Municipal Rollouts, Strong Network Effects
Two additional municipalities launched Dosell in November, both with highly positive outcomes in a short time. One municipality has already placed an additional order for 15 units, clearly showing how the user experience translates quickly into concrete demand.

As we’ve heard before, the feedback has once again been unanimous:
“It’s so user-friendly to operate, it meets all our needs, and the lightweight design is a big plus!”

In addition, five more municipalities have signed agreements to launch Dosell in December and January. During November, we also presented Dosell to 14 new municipalities, and we’re seeing a strong network effect — more and more reference their neighboring municipalities using Dosell and share positive feedback, which strengthens both our credibility and our pipeline going into 2026.

Norway – First Public Procurement Won
Together with our new partner Vakt og Alarm, we have now won a public procurement in Norway that will bring Dosell to six municipalities starting February 1. This marks an important step in our ambition to establish ourselves in the Norwegian market in 2026, much like we have successfully done in Sweden this year.

Finland – Strong Presence and Growing Awareness
In November, we participated in KOPA 2025, Finland’s largest trade fair for municipal home care and assisted living, together with our partner AddSecure. This gave us the opportunity to present Dosell to a wide range of decision-makers and once again, the response was clear:
“This is exactly the kind of solution we’ve been missing in Finland.”

We have now finalized all technical preparations for launch, including integration with UMO/Enovation, training, and workflow configurations. We are fully ready to begin broader rollouts together with AddSecure, with a tested and integrated technical environment in place.

Iceland – New Market, Strong Partner
In November, we launched our new partnership with Skand in Iceland. Our new partner will work with both public and private sector stakeholders (B2B), as well as directly with consumers (B2C). Skand is a well-established player with strong drive and high ambitions, and we look forward to establishing Dosell in another new market where interest is already evident.

The Netherlands – Continued Growth After the Acquisition
Our Dutch subsidiary continues to grow steadily, and the integration is moving ahead rapidly. The team is working closely with both existing and new customers, and in November we increased the number of active units and initiated deployments with several new care organizations. This growth reaffirms Dosell’s strong position in the Dutch market.

We are simultaneously driving multiple improvement initiatives in packaging, installation, and system integrations — all aimed at enhancing user experience and streamlining implementation. Our local presence continues to prove a strategic advantage, creating business value and strengthening customer relationships. Insights from the Netherlands are already proving valuable as we scale in other European markets.

ADDA – Procurement Reissued
The ADDA procurement process has been reissued following minor revisions — something that is common in larger framework agreements. The new deadline for submissions is January 5. For us, this is simply a shift in timing. Our work continues as planned, and several municipalities have already signaled their intention to procure Dosell once the agreement is in place.

Looking Ahead – A Strong Finish to the Year
As we enter the final month of the year, our focus is on delivering according to plan. On the agenda:

  • New municipal implementations
  • Rollout in five new municipalities in Sweden
  • Preparations for first customers in Norway (launching February 1)
  • Launch of Dosell in Iceland – both B2B and B2C
  • Continued growth in the Netherlands – new customers and more units
  • Ongoing pilot discussions and presentations in Sweden
  • Final submission for the ADDA procurement (January 5)
  • Ongoing technical integrations and support
  • Follow-up from the KOPA trade fair in Finland


Thank You for Your Support – We’re Just Getting Started
We remain a small but highly dedicated team, and our strategy is clearly delivering results. With over 30 municipalities now using Dosell in Sweden, operations launched in five European countries, and a growing stream of new customers and deals, we head into 2026 with both momentum and direction.

Thank you for following our journey.
Together, we are building the future of medication management.